
|Videos|October 11, 2016
Evidence and Outcomes in Atopic Dermatitis
Advertisement
Panelists Peter L. Salgo, MD; Jeffrey D. Dunn, PharmD, MBA; Ed Pezalla, MD, MPH; Jonathan Silverberg, MD, PhD, MPH; and Cheryl Allen, BS Pharm, MBA, provide insight on the evidence and outcomes in atopic dermatitis and how they impact coverage.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
TrumpRx Launches, Offering Cash-Paying Patients Discounted Drugs
2
SGLT2 Inhibitors in T2D Lower 5-Year Risk of CKD and Acute Kidney Injury
3
Pharmacist Takeover: CAR T Therapy Signals a Shift in ALL Treatment
4
Balancing Survival and Quality of Life in Pancreatic Cancer: Expert Perspectives From an Immuneering Panel
5


























